immutep (asx:imm, nasdaq:immp) - sharecafe's "hidden gems" presentation, 17 february 2023
Published 1 year ago • 58 plays • Length 15:49
Download video MP4
Download video MP3
Similar videos
-
12:28
immutep (asx:imm, nasdaq:immp) ceo marc voigt provides an update on clinical trials
-
16:07
immutep (asx:imm) - webinar presentation
-
16:06
immutep (asx:imm) - webinar presentation
-
10:01
immutep limited (asx:imm, nasdaq:immp) encouraging results for immutep's cancer therapies
-
52:08
immutep (asx:imm, nasdaq:immp) global webcast presentation at sitc 2022
-
31:08
immutep (asx:imm) 2023 agm - ceo presentation
-
4:44
immutep (asx:imm, nasdaq:immp) - innovative cancer therapies
-
8:12
part 2 "marking candle 8am" (tkzamw)
-
5:54
how to buy amanah saham malaysia 3 through myasnb and maybank m2u (2024 asm3 tutorial)
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
6:25
immutep (asx:imm, nasdaq:immp) discusses a transformative year for lag-3 therapies
-
47:53
immutep (asx:imm, nasdaq:immp) tacti-003 results, june 2024
-
5:42
immutep (asx:imm, nasdaq:immp) receives fast track designation from fda - october 12, 2022
-
27:17
immutep limited (asx:imm, nasdaq:immp) - fireside chat with immutep limited
-
7:09
immutep (asx:imm, nasdaq:immp) reports 71.4% response rate for lung cancer therapy, october 31, 2023
-
46:43
immutep limited (asx:imm, nasdaq:immp) - webcast presentation for cohort b of tacti-003 trial
-
7:13
from the helm: immutep's (asx:imm, nasdaq:immp) executive director & ceo marc voigt
-
3:33
immutep (asx:imm) reports positive trial data
-
6:03
immutep (asx:imm, nasdaq:immp) reports positive discussions with the fda and strong survival data
-
4:19
immutep (asx:imm) clinical trial update
-
4:40
immutep (asx:imm, nasdaq:immp) announces encouraging trial data for lung cancer therapy
Clip.africa.com - Privacy-policy